CollPlant Biotechnologies Ltd.
CLGN
$0.37
$0.000.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -130.51% | 62.56% | 10.36% | ||
| Total Depreciation and Amortization | -6.15% | 0.83% | -5.10% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -29.35% | 8.76% | -24.52% | ||
| Change in Net Operating Assets | 218.02% | -89.01% | -218.18% | ||
| Cash from Operations | -109.08% | 66.31% | -0.46% | ||
| Capital Expenditure | 66.67% | 84.75% | 57.86% | ||
| Sale of Property, Plant, and Equipment | -100.00% | 0.00% | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | 62.50% | 86.21% | 58.57% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -- | -- | ||
| Foreign Exchange rate Adjustments | 3,900.00% | -98.33% | 53.85% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 159.54% | 66.09% | 2.45% | ||